The following clinically significant adverse reactions associated with Eltrombopag are described in other sections.
Hepatic Decompensation in Patients with Chronic Hepatitis C
Hepatotoxicity
Increased Risk of Death and Progression of Myelodysplastic Syndromes to Acute Myeloid Leukemia
Thrombotic/Thromboembolic Complications
from FDA,2021.10
Eltrombopag is an important drug for the treatment of thrombocytopenia, and its ···【more】
Release date:2025-03-24Recommended:77
Understanding the potential side effects of medications can help you manage heal···【more】
Release date:2025-03-21Recommended:49